Accelerating Access to Cell Therapy
Services
acCELLapy supports both medical oncology providers, existing stem cell transplant programs and biotechs, understanding that resolving the disconnect between these stakeholders is critical to expanding access to patients in need. We aspire to develop long term, collaborative relationships with oncology programs, taking great pride in the collective impact we are having in advancing cancer patient care.
For Cancer Programs
Our services are designed to overcome the barriers - real and perceived - to providing Cell Therapy. From offering a targeted, current program capability review through to acting as a co-management service for specific Cell Therapy program requirements, acCELLapy brings bespoke expertise and assurance to allow a cancer program to rapidly and safely commence Cell Therapy services.
For more details on our services for cancer programs, click here
For Biotechs
acCELLapy understands the challenge biotechs face in ensuring life-saving and enhancing Cell Therapy products reach patients in need. Through a network of relationships with Cell Therapy programs and customized tools to efficiently assess the opportunity at new sites, acCELLapy supports biotechs expand access and improve communications with clinical leaders.
For more details on our services for biotechs, click here